Ivan S. Coulter

764 total citations
22 papers, 632 citations indexed

About

Ivan S. Coulter is a scholar working on Pharmaceutical Science, Molecular Biology and Epidemiology. According to data from OpenAlex, Ivan S. Coulter has authored 22 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Ivan S. Coulter's work include Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Ivan S. Coulter is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Ivan S. Coulter collaborates with scholars based in Ireland, Sweden and Brazil. Ivan S. Coulter's co-authors include Mónica Rosa, Tanira Alessandra Silveira Aguirre, David J. Brayden, Marı́a José Alonso, Desirée Teijeiro‐Osorio, Cormac T. Taylor, Murtaza M. Tambuwala, Eoin P. Cummins, Mario C. Manresa and Ed C. Lavelle and has published in prestigious journals such as Gastroenterology, Advanced Drug Delivery Reviews and Gut.

In The Last Decade

Ivan S. Coulter

22 papers receiving 616 citations

Peers

Countries citing papers authored by Ivan S. Coulter

Since Specialization

Citations

This map shows the geographic impact of Ivan S. Coulter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan S. Coulter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan S. Coulter more than expected).

Fields of papers citing papers by Ivan S. Coulter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan S. Coulter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan S. Coulter. The network helps show where Ivan S. Coulter may publish in the future.

Co-authorship network of co-authors of Ivan S. Coulter

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan S. Coulter. A scholar is included among the top collaborators of Ivan S. Coulter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan S. Coulter. Ivan S. Coulter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease 2021 ·Transplant Immunology ·(unknown), (unknown), Ivan S. Coulter, Karen English	3
2	Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease 2021 ·Stem Cell Research & Therapy ·(unknown), (unknown), (unknown), Ivan S. Coulter, (unknown), Catherine Flynn, Karen English	13
3	Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo 2020 ·Journal of Medical Microbiology ·(unknown), Órla O’Sullivan, Paul D. Cotter, Paula M. O’Connor, Fergus Shanahan, (unknown), Mary C. Rea, Colin Hill, Ivan S. Coulter, R. Paul Ross	12
4	Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming 2019 ·Vaccine ·Craig P. McEntee, (unknown), Natalia Muñoz‐Wolf, (unknown), Elizabeth C. Carroll, (unknown), Ivan S. Coulter, Peter Andersen, Frank Follmann, Ed C. Lavelle	4
5	An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses 2019 ·npj Vaccines ·Stéphanie Longet, Áine Abautret-Daly, Christopher J.H. Davitt, Craig P. McEntee, (unknown), Mónica Rosa, Ivan S. Coulter, Jan Holmgren, Sukanya Raghavan, Ed C. Lavelle	34
6	Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines 2019 ·Mucosal Immunology ·Christopher J.H. Davitt, Stéphanie Longet, Aqel Albutti, (unknown), (unknown), (unknown), Craig P. McEntee, Mónica Rosa, Ivan S. Coulter, Michael Lebens, Joshua Tobias, Jan Holmgren, Ed C. Lavelle	19
7	Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis 2019 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·(unknown), (unknown), Eric J. Brown, Catherine Rowan, Ivan S. Coulter, Glen Doherty, Murtaza M. Tambuwala, Cormac T. Taylor	11
8	P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS 2019 ·Gastroenterology ·Jean‐Frédéric Colombel, Ivan S. Coulter, Jesse Hall, (unknown), (unknown), (unknown)	3
9	P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS 2019 ·Inflammatory Bowel Diseases ·Jean‐Frédéric Colombel, Ivan S. Coulter, Jesse B. Hall, Mónica Rosa, Bernard McDonald, (unknown)	1
10	Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation 2017 ·International Journal of Pharmaceutics ·Stéphanie Longet, (unknown), (unknown), Joshua Tobias, Mónica Rosa, Jan Holmgren, Ivan S. Coulter, Ed C. Lavelle	6
11	Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage 2016 ·Journal of Controlled Release ·Tanira Alessandra Silveira Aguirre, (unknown), Mónica Rosa, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann, Ivan S. Coulter, David J. Brayden	16
12	A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens 2016 ·Journal of Controlled Release ·Christopher J.H. Davitt, Edel A. McNeela, Stéphanie Longet, Joshua Tobias, (unknown), Craig P. McEntee, Mónica Rosa, Ivan S. Coulter, Jan Holmgren, Ed C. Lavelle	26
13	Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials 2016 ·Advanced Drug Delivery Reviews ·Tanira Alessandra Silveira Aguirre, Desirée Teijeiro‐Osorio, Mónica Rosa, Ivan S. Coulter, Marı́a José Alonso, David J. Brayden	234
14	Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis 2015 ·Journal of Controlled Release ·Murtaza M. Tambuwala, Mario C. Manresa, Eoin P. Cummins, (unknown), Ivan S. Coulter, Cormac T. Taylor	68
15	In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin 2015 ·European Journal of Pharmaceutical Sciences ·Tanira Alessandra Silveira Aguirre, Mónica Rosa, Ivan S. Coulter, David J. Brayden	24
16	Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres 2015 ·Drug Development and Industrial Pharmacy ·Kieran Keohane, Mónica Rosa, Ivan S. Coulter, Brendan T. Griffin	32
17	Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models 2014 ·European Journal of Pharmaceutics and Biopharmaceutics ·Tanira Alessandra Silveira Aguirre, Mónica Rosa, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann, Ivan S. Coulter, David J. Brayden	33
18	COLON TARGETED, LOW SYSTEMIC ABSORPTION SOLUBLE CICLOSPORIN IN ULCERATIVE COLITIS 2013 ·Gut ·Diarmuid P. O’Donoghue, Stuart Bloom, Ivan S. Coulter	4
19	Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib 2013 ·Pharmaceutical Development and Technology ·(unknown), Ivan S. Coulter, I. W. Marison	8
20	Type I cadherins are required for differentiation and coordinated rotation in Xenopus laevis somitogenesis 2002 ·The International Journal of Developmental Biology ·Emiliana Giacomello, (unknown), Olivier G. Morali, Ivan S. Coulter, Habib Boulekbache, Jean Paul Thiery, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact